Samuel E Williamson

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 11

Top Topics

Emergency Department

Molecular Docking

Bipolar Disorder

Top Venues

ACS chemical neuroscience

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander M Sherwood, Elise K Burkhartzmeyer, Samuel E Williamson, Michael H Baumann, Grant C Glatfelter
Psychedelic-like Activity of Norpsilocin Analogues. ACS chemical neuroscience 15 (2) (2024)
Alexander M Sherwood, Elise K Burkhartzmeyer, Samuel E Williamson, Michael H Baumann, Grant C Glatfelter
Psychedelic-like Activity of Norpsilocin Analogues. ACS chemical neuroscience 15 (2) (2024)
Alexander M Sherwood, Elise K Burkhartzmeyer, Samuel E Williamson, Michael H Baumann, Grant C Glatfelter
Psychedelic-like Activity of Norpsilocin Analogues. ACS chemical neuroscience 15 (2) (2024)
Alexander M Sherwood, Elise K Burkhartzmeyer, Samuel E Williamson, Michael H Baumann, Grant C Glatfelter
Psychedelic-like Activity of Norpsilocin Analogues. ACS chemical neuroscience 15 (2) (2024)
Alexander M Sherwood, Elise K Burkhartzmeyer, Samuel E Williamson, Michael H Baumann, Grant C Glatfelter
Psychedelic-like Activity of Norpsilocin Analogues. ACS chemical neuroscience (2024)
Alexander M Sherwood, Elise K Burkhartzmeyer, Samuel E Williamson, Michael H Baumann, Grant C Glatfelter
Psychedelic-like Activity of Norpsilocin Analogues. ACS chemical neuroscience 15 (2) (2024)
Alexander M Sherwood, Elise K Burkhartzmeyer, Samuel E Williamson, Michael H Baumann, Grant C Glatfelter
Psychedelic-like Activity of Norpsilocin Analogues. ACS chemical neuroscience 15 (2) (2024)
Ross van de Wetering, Amy Ewald, Susan Welsh, Lindsay Kornberger, Samuel E Williamson, Bryan D McElroy, Eduardo R Butelman, Thomas Edward Prisinzano, Bronwyn M Kivell
The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors. Molecules (Basel, Switzerland) 28 (12) (2023)
Ross van de Wetering, Amy Ewald, Susan Welsh, Lindsay Kornberger, Samuel E Williamson, Bryan D McElroy, Eduardo R Butelman, Thomas Edward Prisinzano, Bronwyn M Kivell
The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors. Molecules (Basel, Switzerland) 28 (12) (2023)
Ross van de Wetering, Amy Ewald, Susan Welsh, Lindsay Kornberger, Samuel E Williamson, Bryan D McElroy, Eduardo R Butelman, Thomas Edward Prisinzano, Bronwyn M Kivell
The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors. Molecules (Basel, Switzerland) 28 (12) (2023)
Ross van de Wetering, Amy Ewald, Susan Welsh, Lindsay Kornberger, Samuel E Williamson, Bryan D McElroy, Eduardo R Butelman, Thomas Edward Prisinzano, Bronwyn M Kivell
The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors. Molecules (Basel, Switzerland) 28 (12) (2023)